Gaining perspective on messenger RNA coronavirus disease 2019 vaccination risk
Discussing COVID-19 vaccinations will be ongoing ad infinitum. “Vaccine makers should target the XBB variant of the coronavirus in a shot to be available in the fall,” according to an advisory panel to the Food and Drug Administration. Although the COVID-19 landscape has improved this year, “those who remain vulnerable include the unvaccinated; people who are immunocompromised; and those who have diabetes or chronic kidney, lung, cardiovascular or neurologic diseases. People 65 and older are also at risk and that rises with age.”1
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Warren R. Heymann Tags: A clinician's perspective Source Type: research
More News: Academies | Brain | Cardiology | Cardiovascular | Coronavirus | Covid Vaccine | COVID-19 | Dermatology | Diabetes | Endocrinology | Food and Drug Administration (FDA) | Heart | Neurology | Skin | Urology & Nephrology | Vaccines